Kayla Scott
Gerontology · Demopolis, ALNPI 1518503747
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,505 of the $4,032 with a category attached, or 86.9%. It is spread thinly across 41 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,927 and has fallen 88.4% since, to $224 in 2025.
Across 180 payments — averaging $22.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$741
- Pfizer$318
- Lilly USA, LLC$293
- Novartis$270
- Dendreon Pharmaceuticals LLC$241
- E.r. Squibb & Sons, L.L.C.$218
- plus $2K from 35 others
What the payments were for
- Food & beverage$3,50587%
- Education$52713%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 24 | $741 |
| Pfizer | 21 | $318 |
| Lilly USA, LLC | 8 | $293 |
| Novartis | 14 | $270 |
| Dendreon Pharmaceuticals LLC | 6 | $241 |
| E.r. Squibb & Sons, L.L.C. | 16 | $218 |
| AstraZeneca | 11 | $212 |
| Bristol Myers Squibb | 11 | $212 |
| Johnson & Johnson | 9 | $171 |
| Astellas Pharma US Inc | 4 | $141 |
| AVEO Pharmaceuticals, Inc. | 2 | $119 |
| Sanofi | 4 | $90 |
| Eisai Inc. | 4 | $82 |
| Sobi, Inc | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Puma Biotechnology, Inc. | 3 | $65 |
| Tersera Therapeutics LLC | 2 | $57 |
| AbbVie | 3 | $51 |
| Progenics Pharmaceuticals, Inc. | 3 | $49 |
| Seagen Inc. | 3 | $48 |
| EMD Serono, Inc. | 2 | $43 |
| Merck | 2 | $41 |
| Recordati_rare_diseases_inc. | 2 | $40 |
| G1 Therapeutics, Inc. | 2 | $38 |
| Mirati Therapeutics, Inc. | 2 | $34 |
| Sun Pharmaceutical Industries Inc. | 1 | $29 |
| Stemline Therapeutics Inc. | 1 | $26 |
| Beigene USA, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $21 |
| Novocure Inc. | 1 | $21 |
| Spectrum Pharmaceuticals Inc. | 1 | $20 |
| Genmab U.S., Inc. | 1 | $19 |
| Apellis Pharmaceuticals, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Bayer | 1 | $17 |
| Servier Pharmaceuticals LLC | 1 | $16 |
| GSK | 1 | $15 |
| Karyopharm Therapeutics Inc. | 1 | $14 |
| Pharmaessentia USA Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$166
How this compares
$4,032 in reported general payments places this provider in the 85th percentile of 143 gerontology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gerontology in Demopolis
- Ryan ShannonMontgomery$66K
- Claire BruceHuntsville$12K
- Michelle SanfordMobile$11K
- Virginia McNeillNorthport$11K
- Esther LangeBirmingham$10K
- Sari CapiloutoMontgomery$9K
- Melissa WatkinsDothan$8K
- Melissa HornBirmingham$7K
- Rachel HawesBirmingham$7K
- Stephanie FoutsMobile$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.